20/20 BioLabs announced an investor webinar on November 4, 2026, where CEO Jonathan Cohen will discuss the company's strategy to expand its OneTest™ cancer detection test through laboratory franchises, licensing plans for 2027, potential acquisitions, and FDA approval efforts. The webinar will also cover new Maryland legislation aimed at expanding firefighter cancer screening programs using OneTest™. This event highlights the company's growth plans and regulatory strategies to increase access to early cancer detection. A replay and promotional discount for OneTest™ will be available to attendees.
20/20 BioLabs announced an investor webinar on November 4, 2026, about its OneTest™ commercial expansion and growth strategy. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 19:12 WIB: out of 150 priced US health stocks, 91 rose and 53 fell. Notable movers include HLN at USD 8.62 with a -13.80% change, TDOC at USD 7.66 with +11.34%, and ALNY at USD 209.65 with -9.79% and a near-even buy/sell split.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
